Tajika Masahiro, Tanaka Tsutomu, Oonishi Sachiyo, Yamada Keisaku, Kamiya Tomoyasu, Mizuno Nobumasa, Kuwahara Takamichi, Okuno Nozomi, Haba Shin, Kuraishi Yasuhiro, Ouchi Akira, Sato Yusuke, Kinoshita Takashi, Komori Koji, Hara Kazuo, Hosoda Waki, Niwa Yasumasa
Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
J Clin Med. 2022 Jun 20;11(12):3562. doi: 10.3390/jcm11123562.
In patients with familial adenomatous polyposis (FAP), adenomas and even carcinomas may develop in the rectal remnant and the ileal pouch after surgical treatment. The aim of this study was to evaluate the outcome of endoscopic management in patients with FAP. The main outcome measurements were the appearance of secondary cancer, complications, and the need for additional surgery. Thirty-four FAP patients with Kock’s continent ileostomy (Kock) (n = 3), ileorectal anastomosis (IRA) (n = 12), and ileal pouch-anal anastomosis (IPAA) (n = 19) were identified. The median follow-up period of endoscopic surveillance was 11.5 years for pouch patients (Kock + IPAA) and 21.7 years for IRA. Metachronous adenomas appeared in 32 patients (94.1%). In pouch patients, a total of 120 treatments were given to 20 patients, and 12 sessions of delayed bleeding (10%) occurred, which was significantly higher compared to IRA patients, with 0 sessions (p < 0.001). In IRA patients, a total of 169 treatments were given to 11 patients, with one case of perforation. No adenocarcinoma has developed since the start of endoscopic surveillance. Regular endoscopic surveillance and treatment are feasible and safe. However, in pouch patients, one must be cautious about delayed bleeding in the treatment of adenomas.
在家族性腺瘤性息肉病(FAP)患者中,手术治疗后直肠残端和回肠贮袋可能会发生腺瘤甚至癌。本研究的目的是评估FAP患者内镜治疗的结果。主要结局指标为继发性癌症的出现、并发症以及是否需要再次手术。共纳入34例FAP患者,其中采用Kock可控性回肠造口术(Kock)的有3例,回肠直肠吻合术(IRA)的有12例,回肠贮袋肛管吻合术(IPAA)的有19例。贮袋患者(Kock + IPAA)内镜监测的中位随访期为11.5年,IRA患者为21.7年。32例患者(94.1%)出现异时性腺瘤。在贮袋患者中,20例患者共接受了120次治疗,发生12次延迟出血(10%),与IRA患者0次相比显著更高(p < 0.001)。在IRA患者中,11例患者共接受了169次治疗,有1例穿孔。自内镜监测开始以来未发生腺癌。定期内镜监测和治疗是可行且安全的。然而,对于贮袋患者,在腺瘤治疗中必须警惕延迟出血。